Pfizer is sued by Texas over COVID-19 vaccine claims
By Jonathan Stempel Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the
1970-01-01 08:00
Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug
By Brendan Pierson Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children's
1970-01-01 08:00
Pfizer swings to loss as COVID product demand slump sparks charges
(Reuters) -Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it
1970-01-01 08:00
Pfizer, BioNtech say flu-COVID shot generates immune response
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a
1970-01-01 08:00
BioNTech will likely take 900 million eur write-off on Pfizer-partnered vaccines
BERLIN Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947
1970-01-01 08:00
Pfizer lowers full-year revenue forecast, shares fall
Pfizer Inc on Friday cut forecast for 2023 revenue to between $58 billion and $61 billion, from $67
1970-01-01 08:00
Pfizer responds to Aaron Rodgers diss on Travis Kelce in the best possible way
Pfizer just had to get in on the Aaron Rodgers-Travis Kelce vaccine debate.
1970-01-01 08:00
EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal
BRUSSELS Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a
1970-01-01 08:00
US FDA approves Pfizer's maternal RSV vaccine to protect infants
By Patrick Wingrove and Bhanvi Satija The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial
1970-01-01 08:00
US FDA approves Pfizer's blood cancer therapy
(Reuters) -The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's therapy for treating patients with a
1970-01-01 08:00
GSK sues Pfizer in US for patent infringement over RSV vaccine
By Blake Brittain (Reuters) -British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory
1970-01-01 08:00
AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 billion
(Reuters) -AstraZeneca said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's early-stage rare disease gene therapy
1970-01-01 08:00